Press
- (中文) 无论License in还是License out，如何找到对的“她”是关键！
- GBI hosts webinar on: “China’s 3rd Volume Based Procurement (VBP) batch: results and analysis”
- (中文) 居安思危，以人为本 | 后疫情时代，中国医药产业现状及思考
- GBI and Bloomberg Co-Host Webinar on China’s PD-1/L1 Drug R&D and Vaccines Opportunities
- (中文) 第三批VBP大战在即！傲娇坚守底线or忍痛以价换量，看完本文不纠结
- GBI announces the launch of its new, global pharmaceutical API platform and its first client for data service
- (中文) 注射剂不过评就是死路一条！363个品种“最强大脑”现场一一点评
- (中文) 57%受访者离职竟然是因为直线经理？跳槽涨薪幅度还从35%跌到0%？谁是疫情下的逆行者
- (中文) GBI成功举办新修订药品注册管理办法专题在线课程
- (中文) GBI专题报告 | 疫情催化下，互联网医疗再提速
